The question is how much delay for an answer from the EU. It is not devastating if Prana get on to it quickly and minimize the dead time between now and the EU submission/decision. We don't know if they need to change anything as a result of the FDA discussions. For me Pixi it has always been the better option to do the trial ex USA. Probably cheaper also.
They were speaking about other ways to increase shareholder value. That could be interesting if it is not just a standard statement.
Ann: Prana provides regulatory update for PBT2-PBT.AX, page-30
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $7.5K | 1.5M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 63305651 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 38258482 | 22 |
View Market Depth
| Last trade - 10.00am 12/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |